Grusha Y O, Kochetkov P A, Ismailova D S, Svistushkin V M, Zhorzholadze N V, Spychak V Y
Research Institute of Eye Diseases, Moscow, Russia.
I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovskiy University), Moscow, Russia.
Vestn Otorinolaringol. 2020;85(6):52-55. doi: 10.17116/otorino20208506152.
To estimate efficacy and safety of endoscopic orbital decompression in patients with dysthyroid optic neuropathy (DON).
19 patients aged 54.8±7.1 y.o. with DON were enrolled into the study.
Visual acuity was from counting fingers till 0.9 (0.4±0.28) before surgery, it increased till 0.7±0.2 (<0.05) after surgery. The amount of correct Ishihara plates increased from 5.8±7 till 13.3±7.6 (<0.05). Exophthalmos reduced by 1.7 mm (<0.05). Significant reduce of orbital inflammation was noted as well.
This study is the first study of this kind in Russian Federation. Obtained results showed high efficacy and safety of endoscopic orbital decompression in patients with DON.
评估内镜下眼眶减压术治疗甲状腺相关性视神经病变(DON)患者的疗效和安全性。
19例年龄为54.8±7.1岁的DON患者纳入本研究。
术前视力从指数到0.9(0.4±0.28),术后提高到0.7±0.2(<0.05)。石原氏色盲测试板正确识别数量从5.8±7增加到13.3±7.6(<0.05)。眼球突出度降低了1.7毫米(<0.05)。眼眶炎症也显著减轻。
本研究是俄罗斯联邦首例此类研究。所得结果表明内镜下眼眶减压术治疗DON患者具有较高疗效和安全性。